Advertisement

Cefazolin Injection

[18 July 2014]

Products Affected - Description

Cefazolin injection, Fresenius Kabi
500 mg, 1 count (NDC 63323-0236-10)
1 gram, 25 count (NDC 63323-0237-10)
10 gram, 1 count (NDC 63323-0238-61)
20 gram, 1 count (NDC 63323-0446-66)

Cefazolin injection, Apotex
1 gram, 10 count (NDC 60505-0749-04) - discontinued
10 gram, 1 count (NDC 60505-0769-00)
 
Cefazolin injection, BBraun
1 gram/50 mL premix (NDC 00264-3103-11)
Cefazolin injection, Hospira
1 gram, Add-Vantage vial, 25 count (NDC 00409-2585-01)
1 gram, 25 count (NDC 00409-0805-01)
10 gram, 10 count (NDC 00409-0806-01)
 
Cefazolin injection, Sagent
500 mg, 25 count (NDC 25021-0100-10)
1 gram, 25 count (NDC 25021-0101-10)
10 gram, 1 count (NDC 25021-0102-99) 
 
Cefazolin injection, Sandoz
500 mg, 10 count (NDC 00781-3450-95)
1 gram, 25 count (NDC 00781-3451-96)
10 gram, 10 count (NDC 00781-3452-95) 
 
Cefazolin injection, West-Ward
500 mg, 25 count (NDC 00143-9923-90)
1 gram, 25 count (NDC 00143-9924-90)
10 gram, 10 count (NDC 00143-9983-03)
 
Cefazolin injection, WG Critical Care
500 mg, 25 count (NDC 44567-0706-25)
1 gram, 25 count (NDC 44567-0707-25)
10 gram, 10 count (NDC 44567-0708-10)
20 gram, 10 count (NDC 44567-0709-10)

Reason for the Shortage

  • Fresenius Kabi, BBraun, West-Ward, and WG Critical Care have cefazolin on shortage due to increased demand.
  • Apotex and Sandoz have cefazolin on shortage due to manufacturing delays.
  • Hospira has cefazolin on shortage due to manufacturing delays and increased demand.
  • Sagent has cefazolin on shortage due to increased demand and shipping delays.

Available Products

Cefazolin injection, Apotex
1 gram, 25 count (NDC 60505-0749-05)
10 gram, 1 count, Novaplus vials (NDC 60505-6094-00)
1 gram, 25 count, Novaplus vials (NDC 60505-6093-05)
 
Cefazolin injection, Baxter
1 gram/ 50 mL premix (NDC 00338-3503-41)
 
Cefazolin injection, BBraun
2 gram/50 mL premix (NDC 00264-3105-11)
 
Cefazolin injection, Samson Medical Technologies
100 mg SmartPak bulk package (NDC 66288-1100-01)
300 mg SmartPak bulk package (NDC 66288-1300-01)

Estimated Resupply Dates

  • Fresenius Kabi has cefazolin 500 mg and 1 gram vials on back order and the company estimates a release date of mid-August 2014. Cefazolin 10 gram vials are on back order and the company estimates a release date in early-August 2014. Cefazolin 20 gram vials are on back order and the company cannot estimate a release date.
  • Apotex has cefazolin 10 gram vials on back order and the company estimates a release date in late-July to early-August 2014.
  • BBraun has cefazolin 1 gram/50 mL premix on allocation.
  • Hospira has cefazolin 1 gram, 1 gram Add-vantage, and 10 gram vials on back order and the company cannot estimate a release date.
  • Sagent has cefazolin 500 mg and 10 gram vials on back order and the company estimates a release date of July 2014. Cefazolin 1 gram vials are on intermittent back order and the company is releasing product as it becomes available.
  • Sandoz has cefazolin 500 mg vials, 1 gram vials, and 10 gram vials on intermittent back order and the company is releasing product as it becomes available.
  • West-Ward has cefazolin 500 mg, 1 gram, and 10 gram vials available on allocation.
  • WG Critical Care has cefazolin 1 gram vials available in limited supply. Check with your wholesaler for availability. Cefazolin 500 mg vials are on back order and the company estimates a release date in early-August 2014. Cefazolin 20 gram vials are on back order and the company cannot estimate a release date.

Related Shortages

Updated

July 18, 2014; June 26, 2014; June 13, 2014; May 28, 2014; May 12, 2014; May 8, 2014; April 30, 2014; April 15, 2014; April 2, 2014; March 25, 2014; March 18, 2014; March 5, 2014; February 19, 2014; February 10, 2014; January 29, 2014; January 24, 2014; January 21, 2014; January 6, 2014; December 19, 2013; December 3, 2013; November 13, 2013; October 30, 2013; October 21, 2013; October 10, 2013; September 23, 2013; September 3, 2013; August 27, 2013; August 13, 2013; August 1, 2013; July 18, 2013; July 3, 2013; June 6, 2013; May 30, 2013; May 6, 2013; April 12, 2013; April 1, 2013; March 29, 2013; March 7, 2013; February 12, 2013; February 5, 2013; January 23, 2013; January 10, 2014, University of Utah, Drug Information Service. Copyright 2014, Drug Information Service, University of Utah, Salt Lake City, UT.

Disclaimer

This information is provided through the support of Novation to ASHP solely as a service to its members, which shall not use this information for their further commercial use. The content was prepared by the Drug Information Center of University of Utah. Novation, ASHP, and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, which respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither Novation, ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this bulletin. Neither Novation, ASHP nor University of Utah endorses or recommends the use of any drug.

« Back to Drug Shortage Product Bulletins

Advocacy Activity
Get the latest updates on ASHP's advocacy activity on drug shortages.
Advertisement